Alpha-synuclein phosphorylation induces amyloid conversion via enhanced electrostatic bridging: Insights from molecular modeling of the full-length protein
Biophysical Chemistry · 2024
DOI: 10.1016/j.bpc.2024.107196 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biophysical Chemistry, 2024. Verfasst von Pavel I Semenyuk. Beteiligte Einrichtung: Belozersky Research Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119991 Moscow, Leninskie gory 1/40, Russia. Electronic …. Hauptthemen laut MEDLINE: Parkinson Disease, Synucleinopathies. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: Moscow State University of Geodesy and Cartography, Russian Science Foundation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Belozersky Research Institute of Physico-Chemical Biology, Lomonosov Moscow State University, 119991 Moscow, Leninskie gory 1/40, Russia. Electronic address: psemenyuk@belozersky.msu.ru.
Förderung
- Moscow State University of Geodesy and Cartography
- Russian Science Foundation
Zitieren
APA
Semenyuk, P. I. (2024). Alpha-synuclein phosphorylation induces amyloid conversion via enhanced electrostatic bridging: Insights from molecular modeling of the full-length protein. Biophysical Chemistry. https://doi.org/10.1016/j.bpc.2024.107196
Vancouver
Semenyuk PI. Alpha-synuclein phosphorylation induces amyloid conversion via enhanced electrostatic bridging: Insights from molecular modeling of the full-length protein. Biophysical Chemistry. 2024. doi:10.1016/j.bpc.2024.107196
BibTeX
@article{Semenyuk2024,
author = {Semenyuk, Pavel I},
title = {Alpha-synuclein phosphorylation induces amyloid conversion via enhanced electrostatic bridging: Insights from molecular modeling of the full-length protein},
journal = {Biophysical Chemistry},
year = {2024},
doi = {10.1016/j.bpc.2024.107196}
}
EUVIMED